Home
gMG
NMOSD
Understanding NF1
Diagnosis and management
Impact of NF1-PN
About KOSELUGO®
Efficacy
Safety
Dosing
What is HPP?
About HPP and low ALP
Signs and symptoms
Burden of disease
ALP-based HPP calculator
Complement C5 Inhibition and the Evolution of NMOSD Treatment
April 19th 2024
12.00 – 13.30 CET
I am a healthcare professional registered in the EU
I am not a
healthcare professional
Exit
Continue
